• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌的表观遗传调节剂

Epigenetic modulators of thyroid cancer.

作者信息

Rodríguez-Rodero Sandra, Delgado-Álvarez Elías, Díaz-Naya Lucía, Martín Nieto Alicia, Menéndez Torre Edelmiro

机构信息

Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias (HUCA), Oviedo, Asturias, Spain; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, Spain.

Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias (HUCA), Oviedo, Asturias, Spain.

出版信息

Endocrinol Diabetes Nutr. 2017 Jan;64(1):44-56. doi: 10.1016/j.endinu.2016.09.006. Epub 2017 Jan 20.

DOI:10.1016/j.endinu.2016.09.006
PMID:28440770
Abstract

There are some well known factors involved in the etiology of thyroid cancer, including iodine deficiency, radiation exposure at early ages, or some genetic changes. However, epigenetic modulators that may contribute to development of these tumors and be helpful to for both their diagnosis and treatment have recently been discovered. The currently known changes in DNA methylation, histone modifications, and non-coding RNAs in each type of thyroid carcinoma are reviewed here.

摘要

甲状腺癌的病因涉及一些众所周知的因素,包括碘缺乏、早年辐射暴露或某些基因变化。然而,最近发现了一些可能促成这些肿瘤发生并有助于其诊断和治疗的表观遗传调节因子。本文综述了目前已知的各类甲状腺癌中DNA甲基化、组蛋白修饰和非编码RNA的变化。

相似文献

1
Epigenetic modulators of thyroid cancer.甲状腺癌的表观遗传调节剂
Endocrinol Diabetes Nutr. 2017 Jan;64(1):44-56. doi: 10.1016/j.endinu.2016.09.006. Epub 2017 Jan 20.
2
Genetic mutations in thyroid carcinoma.甲状腺癌中的基因突变
Minerva Endocrinol. 2009 Mar;34(1):11-28.
3
Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.在滤泡性甲状腺增生中,RASSF1A 的启动子甲基化频繁失活:甲状腺癌发生中潜在的早期表观遗传易感性事件。
JAMA Surg. 2014 Nov;149(11):1146-52. doi: 10.1001/jamasurg.2014.1694.
4
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.DNA 甲基化特征可识别生物学上不同的甲状腺癌亚型。
J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21. doi: 10.1210/jc.2012-3566. Epub 2013 May 10.
5
Gene methylation in gastric cancer.胃癌中的基因甲基化。
Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10.
6
RAP1GAP Functions as a Tumor Suppressor Gene and Is Regulated by DNA Methylation in Differentiated Thyroid Cancer.RAP1GAP 作为抑癌基因,其表达受甲状腺癌细胞中 DNA 甲基化调控。
Cytogenet Genome Res. 2021;161(5):227-235. doi: 10.1159/000516122. Epub 2021 Jul 26.
7
[Epigenetic alterations in acute lymphoblastic leukemia].[急性淋巴细胞白血病中的表观遗传改变]
Bol Med Hosp Infant Mex. 2017 Jul-Aug;74(4):243-264. doi: 10.1016/j.bmhimx.2017.02.005. Epub 2017 Jul 15.
8
From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.从结节到分化型甲状腺癌:2012 年分子分析的贡献。
Ann Endocrinol (Paris). 2012 Jun;73(3):155-64. doi: 10.1016/j.ando.2012.03.002. Epub 2012 Apr 13.
9
TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.甲状腺癌中的端粒酶逆转录酶(TERT)启动子突变:来自中东人群的报告。
Endocr Relat Cancer. 2015 Dec;22(6):901-8. doi: 10.1530/ERC-15-0396. Epub 2015 Sep 9.
10
The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).人端粒酶逆转录酶(hTERT)基因启动子区域的DNA甲基化和多态性与甲状腺癌(TC)患者术后复发的相关性。
World J Surg Oncol. 2017 Jun 6;15(1):114. doi: 10.1186/s12957-017-1170-z.

引用本文的文献

1
Epigenetic modifications in follicular cell-derived thyroid cancer: new dimensions in pathogenesis and treatment.滤泡细胞源性甲状腺癌中的表观遗传修饰:发病机制与治疗的新维度
Front Oncol. 2025 May 20;15:1549477. doi: 10.3389/fonc.2025.1549477. eCollection 2025.
2
Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment.具有种系S891A原癌基因突变的甲状腺髓样癌的家族性临床异质性:索拉非尼治疗成功的7年随访
J Clin Res Pediatr Endocrinol. 2025 Aug 22;17(3):345-351. doi: 10.4274/jcrpe.galenos.2023.2023-7-13. Epub 2023 Nov 9.
3
Organochlorine pesticides and epigenetic alterations in thyroid tumors.
有机氯农药与甲状腺肿瘤的表观遗传改变。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1130794. doi: 10.3389/fendo.2023.1130794. eCollection 2023.
4
Multi-Omics and Management of Follicular Carcinoma of the Thyroid.甲状腺滤泡癌的多组学与管理
Biomedicines. 2023 Apr 19;11(4):1217. doi: 10.3390/biomedicines11041217.
5
The Epigenetic Modification of in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features.甲状腺乳头状癌中的表观遗传修饰及其对临床病理特征的影响。
Iran J Public Health. 2022 Mar;51(3):634-642. doi: 10.18502/ijph.v51i3.8940.
6
Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.2型糖尿病性心肌病的表观遗传学研究进展
Front Cell Dev Biol. 2021 Dec 24;9:777258. doi: 10.3389/fcell.2021.777258. eCollection 2021.
7
is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene.在甲状腺乳头状癌中表达下调且高度甲基化,提示其作为肿瘤抑制基因的作用。
Int J Endocrinol Metab. 2020 Oct 19;18(4):e108510. doi: 10.5812/ijem.108510. eCollection 2020 Oct.
8
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.甲状腺肿瘤中的癌症干细胞:从起源到转移。
Front Endocrinol (Lausanne). 2020 Aug 25;11:566. doi: 10.3389/fendo.2020.00566. eCollection 2020.
9
Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.长链非编码 RNA LINC00520 通过作为 microRNA-577 的竞争性内源性 RNA 增加 Sphk2 表达来加速甲状腺乳头状癌的进展。
Cell Cycle. 2020 Apr;19(7):787-800. doi: 10.1080/15384101.2020.1731062. Epub 2020 Feb 20.
10
Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.分化型甲状腺癌中 FSCN1 基因启动子甲基化与 FSCN1 蛋白表达的研究。
Mol Biol Rep. 2020 Mar;47(3):2161-2169. doi: 10.1007/s11033-020-05315-8. Epub 2020 Feb 18.